Cargando…
Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?
Although cytotoxic chemotherapy has been used often in the management of Merkel cell carcinoma (MCC), its benefit remains uncertain. Despite being considered a chemosensitive disease, the duration of response is generally short, and the survival benefit is unclear. With the recent FDA approval of th...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628662/ https://www.ncbi.nlm.nih.gov/pubmed/29033592 http://dx.doi.org/10.2147/OTT.S126640 |